Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control study.
about
Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral TherapyRenal effects of novel antiretroviral drugs.Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.
P2860
Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical features and risk fac ...... thiasis: a case-control study.
@ast
Clinical features and risk fac ...... thiasis: a case-control study.
@en
Clinical features and risk factors for atazanavir
@nl
type
label
Clinical features and risk fac ...... thiasis: a case-control study.
@ast
Clinical features and risk fac ...... thiasis: a case-control study.
@en
Clinical features and risk factors for atazanavir
@nl
prefLabel
Clinical features and risk fac ...... thiasis: a case-control study.
@ast
Clinical features and risk fac ...... thiasis: a case-control study.
@en
Clinical features and risk factors for atazanavir
@nl
P2093
P2860
P1433
P1476
Clinical features and risk fac ...... thiasis: a case-control study.
@en
P2093
Barbara De Sousa
Christophe Rioux
Diane Ponscarme
Erwan Fourn
Jean-Michel Molina
Laurence Weiss
Matthieu Lafaurie
Michel Daudon
Nathanael Lapidus
P2860
P304
P356
10.1371/JOURNAL.PONE.0112836
P407
P577
2014-11-19T00:00:00Z